C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy Full Text
BMC Cancer, 08/03/2012
Ito H et al. – The study demonstrated that the serum C–reactive protein (CRP) level is a statistically significant prognostic parameter for patients with advanced metastatic renal cell carcinoma (AM–RCC). The data also indicated that pretreatment serum CRP level provides useful prognostic information that helps in deciding whether to perform initial nephrectomy for patients with AM–RCC.